The other three studies investigating the relationship between GDF-15 and coronary artery calcification all involved specific patient populations: patients with chronic obstructive pulmonary disease (COPD)[16], end-stage renal disease[17], and psoriasis [18]. Here, GDF15 is linked to stage 5 chronic kidney disease.